Evidence map›Paper›PMID 30167765›Full record

ArticleRheumatology international2018

Validation and cultural adaptation of the qualisex questionnaire in patients with axial spondyloarthritis in Argentina.

Fernando Andres Sommerfleck, Emilce Edith Schneeberger, Maria Celeste Orozco, Natalia Zamora, Margarita Landi, Gustavo Citera

Abstract readValidation Study
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fernando Andres SommerfleckRheumatology Section, Instituto de Rehabilitación Psicofísica, Echeverria 955, Buenos Aires, Argentina. fersommerfleck@gmail.com.ORCID http://orcid.org/0000-0001-6863-7559
Emilce Edith SchneebergerRheumatology Section, Instituto de Rehabilitación Psicofísica, Echeverria 955, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0001-7671-5748
Maria Celeste OrozcoRheumatology Section, Instituto de Rehabilitación Psicofísica, Echeverria 955, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0002-3004-1271
Natalia ZamoraRheumatology Section, Instituto de Rehabilitación Psicofísica, Echeverria 955, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0002-5197-4134
Margarita LandiRheumatology Section, Instituto de Rehabilitación Psicofísica, Echeverria 955, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0002-3349-5519
Gustavo CiteraRheumatology Section, Instituto de Rehabilitación Psicofísica, Echeverria 955, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0002-3724-1874

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Qualisex questionnaire was developed and validated to assess sexuality in patients with rheumatoid arthritis. To the best of our knowledge, there is no instrument to evaluate sexuality in axial spondyloarthritis (axSpA). For this reason, the objective of this study was to validate and adapt the Qualisex questionnaire in axSpA and evaluate the impact of the disease on patients' sexuality. Cross sectional study. Consecutive patients, with ≥ 21 years of age, diagnosed with axSpA according to ASAS'09 criteria were included. Sexual health was assessed using the Qualisex questionnaire. The original version was translated to Spanish and adapted to axSpA. Internal consistency, and test re-test reliability was calculated. Criterion and construct validity were assessed by comparing the Qualisex with parameters of disease activity functional capacity and quality of life. 61 patients were invited to participate in the study, 11 of whom refused. 50 patients were included; 40 (80%) were males, with a median age of 47 years (IQR 21-72) and a median disease duration of 13 years (IQR 1-46). Reproducibility was excellent with an ICC of 0.99 (95% CI 0.65-1). The Qualisex had a good correlation with different disease evaluation parameters. The Qualisex was significantly higher among women (5.4 in women vs. 2.5 in men, p = 0.02), unemployed (4.7 in unemployed vs. 2.3 in employed, p = 0.01), in patients with higher disease activity (4.2 in active patients vs. 1.6 in inactive patients, p = 0.01), and it was lower in patients receiving biologic therapy (BT) (1.9 with BT vs. 3.8 without BT, p = 0.01). Multivariable analysis showed that female sex, longer disease duration and higher disease activity were independently associated with a greater impact on sexuality. The Qualisex adapted to axSpA is a valid and reliable questionnaire. Female axSpA patients, those with longer disease duration and higher disease activity presented a worse sexual life.

Indexed as

SexualitySurveys and QuestionnairesAdultAgedAntirheumatic AgentsArgentinaBiological ProductsCross-Sectional StudiesCultural CharacteristicsFemaleHealth StatusHumansMaleMiddle AgedPredictive Value of TestsPrognosisAntirheumatic AgentsBiological ProductsAnkylosing spondylitisAxial spondyloarthritisPsoriatic arthritisQualisexSexuality

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.